Yeah and BP's earlier full report talks about the entire deal value..
Today they are just pointing out what is expected in the next 6 months if we just get positive Phase 3 results and an EUA approval for COVID-19 ARDS as that is what the fast track is for.. MSB has not got fast track as yet for the broader ARDS indication.
The other milestones linked to broader ARDS indication and commercial milestones will not happen in FY21 but will take longer to get triggered..
Why so quick to react without understanding the significance?
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-144
-
- There are more pages in this discussion • 429 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
0.025(2.67%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 96.5¢ | 94.0¢ | $1.231M | 1.291M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 94461 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 61151 | 6 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |